Carisma Therapeutics Seals Reverse Merger with Sesen Bio, Ready to Take on Clinical Victories in 2023 – Not for the Faint of Heart!
Trending News ☀️ Carisma Therapeutics is no stranger to challenges, and they have certainly taken on a bold endeavor by [...]
Sesen Bio Shareholders Up 6.5% This Week, 21% in Last Quarter, Despite Five Year Losses.
Trending News ☀️ Despite reporting losses in each of the last five years, Sesen Bio ($NASDAQ:SESN) Inc. investors have something [...]
” S e s e n B i o R e p o r t s G A A P E P S o f – $ 0 . 0 4 , B e a t i n g E x p e c t a t i o n s b y $ 0
Trending News 🌥️ Sesen Bio ($NASDAQ:SESN), a life sciences company focused on developing cancer therapies, recently released its fourth quarter [...]
Sesen Bio Gains 11% Pre-Market on Agreement with Key Shareholders to Support Merger with Carisma Therapeutics.
Trending News ☀️ Sesen Bio ($NASDAQ:SESN) is a clinical-stage biopharmaceutical company focused on developing next-generation targeted fusion protein therapeutics for [...]
Sesen Bio Receives Delisting Notice, Emphasizing Need for Merger with Carisma Therapeutics to Avoid Deregistration.
Trending News 🌧️ Sesen Bio ($NASDAQ:SESN), a biopharmaceutical company focused on developing novel targeted therapies to treat cancer, recently received [...]
SESEN BIO Predicted to See Surge in Growth, Say Analysts
Trending News ☀️ Analysts are predicting a surge in growth for SESEN BIO ($NASDAQ:SESN), a leading biopharmaceutical company that focuses [...]
Tuesday Brings 4.2% Stock Rise for Sesen Bio Despite Merger Opposition
Trending News 🌥️ Sesen Bio ($NASDAQ:SESN) is a biopharmaceutical company focusing on the development of novel cancer treatments. On Tuesday, [...]
Analysts Rate Sesen Bio Inc Stock as a “Hold” Despite -1.96% Loss This Week and -43.82% Drop Over Last Year
Trending News 🌥️ Sesen Bio ($NASDAQ:SESN) Inc is a biopharmaceutical company focused on developing targeted fusion protein therapeutics for the [...]
Sesen Bio Reports Q3 EPS and Revenue
Trending News ☀️ Sesen Bio ($NASDAQ:SESN), Inc. is a biopharmaceutical company focused on the development and commercialization of targeted fusion [...]
Sesen Bio progressing with regulators, prepping for new cancer trial despite issues
Trending News 🌧️ Sesen Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cancer therapies. [...]
